Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 229
7
Diseases
34
Unique genes
0.158
Avg. similarity score
Epidermolysis bullosa
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Epidermolysis bullosa
Epidermolysa bullosa simplex and limb girdle muscular dystrophy
Other epidermolysis bullosa
PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder
Aplasia cutis congenita
Junctional epidermolysis bullosa
mucopolysaccharidosis type 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Epidermolysis bullosa | 6 | 6 | 21 |
| Epidermolysa bullosa simplex and limb girdle muscular dystrophy | 5 | 5 | 1 |
| Other epidermolysis bullosa | 5 | 5 | 6 |
| PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder | 5 | 5 | 1 |
| Aplasia cutis congenita | 4 | 4 | 5 |
| Junctional epidermolysis bullosa | 4 | 4 | 18 |
| mucopolysaccharidosis type 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PLEC | 6 / 7 | Aplasia cutis congenita, Epidermolysa bullosa simplex and limb girdle muscular dystrophy, Epidermolysis bullosa, Junctional epidermolysis bullosa and 2 more |
| ITGB4 | 4 / 7 | Aplasia cutis congenita, Epidermolysis bullosa, Junctional epidermolysis bullosa, Other epidermolysis bullosa |
| ITGA6 | 3 / 7 | Epidermolysis bullosa, Junctional epidermolysis bullosa, Other epidermolysis bullosa |
| LAMB3 | 3 / 7 | Epidermolysis bullosa, Junctional epidermolysis bullosa, Other epidermolysis bullosa |
| COL17A1 | 2 / 7 | Junctional epidermolysis bullosa, Other epidermolysis bullosa |
| COL7A1 | 2 / 7 | Epidermolysis bullosa, Junctional epidermolysis bullosa |
| IDS | 2 / 7 | Epidermolysis bullosa, mucopolysaccharidosis type 2 |
| KLHL24 | 2 / 7 | Epidermolysis bullosa, Junctional epidermolysis bullosa |
| KRT14 | 2 / 7 | Epidermolysis bullosa, Junctional epidermolysis bullosa |
| KRT5 | 2 / 7 | Epidermolysis bullosa, Junctional epidermolysis bullosa |
| LAMC2 | 2 / 7 | Junctional epidermolysis bullosa, Other epidermolysis bullosa |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Type I hemidesmosome assembly | Reactome | 11 / 11 | 353× | 1.53e-29 | 4.22e-26 ✓ sig. |
| Assembly of collagen fibrils and other multimeric structures | Reactome | 10 / 51 | 69.3× | 9.07e-17 | 4.14e-14 ✓ sig. |
| Laminin interactions | Reactome | 7 / 28 | 88.3× | 8.56e-13 | 1.89e-10 ✓ sig. |
| ECM-receptor interaction | KEGG | 7 / 89 | 27.8× | 4.42e-9 | 4.24e-7 ✓ sig. |
| Formation of the cornified envelope | Reactome | 7 / 130 | 19.0× | 6.24e-8 | 4.35e-6 ✓ sig. |
| Anchoring fibril formation | Reactome | 4 / 15 | 94.2× | 7.15e-8 | 4.88e-6 ✓ sig. |
| MET activates PTK2 signaling | Reactome | 4 / 30 | 47.1× | 1.39e-6 | 6.51e-5 ✓ sig. |
| Keratinization | Reactome | 6 / 152 | 13.9× | 3.74e-6 | 1.50e-4 ✓ sig. |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 5 / 86 | 20.5× | 3.96e-6 | 1.56e-4 ✓ sig. |
| Small cell lung cancer | KEGG | 5 / 93 | 19.0× | 5.82e-6 | 2.15e-4 ✓ sig. |
| Focal adhesion | KEGG | 6 / 203 | 10.4× | 1.96e-5 | 5.89e-4 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 6 / 232 | 9.1× | 4.16e-5 | 1.10e-3 ✓ sig. |
| Toxoplasmosis | KEGG | 4 / 112 | 12.6× | 2.68e-4 | 4.92e-3 ✓ sig. |
| Human papillomavirus infection | KEGG | 6 / 333 | 6.4× | 3.03e-4 | 5.41e-3 ✓ sig. |
| Apoptotic cleavage of cell adhesion proteins | Reactome | 2 / 11 | 64.2× | 4.21e-4 | 6.96e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| hemidesmosome assembly | GO:0031581 | 5 / 6 | 458× | 8.79e-14 | 4.89e-11 ✓ sig. |
| epidermis development | GO:0008544 | 9 / 114 | 43.4× | 3.92e-13 | 1.94e-10 ✓ sig. |
| cell adhesion | GO:0007155 | 13 / 665 | 10.7× | 6.09e-11 | 1.84e-8 ✓ sig. |
| intermediate filament organization | GO:0045109 | 6 / 70 | 47.1× | 2.75e-9 | 5.47e-7 ✓ sig. |
| cell-cell adhesion | GO:0098609 | 8 / 218 | 20.2× | 4.22e-9 | 8.01e-7 ✓ sig. |
| keratinocyte development | GO:0003334 | 3 / 11 | 150× | 8.99e-7 | 7.60e-5 ✓ sig. |
| skin development | GO:0043588 | 4 / 55 | 40.0× | 2.92e-6 | 1.95e-4 ✓ sig. |
| peptide cross-linking | GO:0018149 | 3 / 19 | 86.8× | 5.23e-6 | 3.11e-4 ✓ sig. |
| keratinocyte differentiation | GO:0030216 | 4 / 69 | 31.9× | 7.26e-6 | 4.04e-4 ✓ sig. |
| intermediate filament cytoskeleton organization | GO:0045104 | 3 / 23 | 71.7× | 9.51e-6 | 5.02e-4 ✓ sig. |
| cell communication | GO:0007154 | 4 / 80 | 27.5× | 1.31e-5 | 6.45e-4 ✓ sig. |
| integrin-mediated signaling pathway | GO:0007229 | 4 / 100 | 22.0× | 3.16e-5 | 1.27e-3 ✓ sig. |
| endodermal cell differentiation | GO:0035987 | 3 / 36 | 45.8× | 3.77e-5 | 1.45e-3 ✓ sig. |
| cell-matrix adhesion | GO:0007160 | 4 / 105 | 20.9× | 3.83e-5 | 1.47e-3 ✓ sig. |
| bundle of His cell-Purkinje myocyte adhesion involved in cell communication | GO:0086073 | 2 / 6 | 183× | 4.80e-5 | 1.74e-3 ✓ sig. |